»ó´Ü¿©¹é
±â»ç (Àüü 407°Ç)
[Sub Story] ¼­±¸È­µÈ Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ÀÌ»óµ· ±âÀÚ 2021-01-04 18:40
[Sub Story] LDL-C ÃÖÀú ¸ñǥġ´Â? ÀÌ»óµ· ±âÀÚ 2021-01-04 18:36
[Sub Story] 70mg/dL ¹Ì¸¸Á¶ÀýÀº ½ºÅ¸Æ¾ÀÇ ¿ª»ç ÀÌ»óµ· ±âÀÚ 2021-01-04 18:30
[Sub Story] Çаè´Â Àü¿¡ ¾ø´ø LDL-C¡é ¿øÇÑ´Ù ÀÌ»óµ· ±âÀÚ 2021-01-04 18:20
[Sub Story] ÄÝ·¹½ºÅ×·Ñ ÇÕ¼º¡¤Èí¼ö ¾ïÁ¦
LDL-C ´õ ÁÙÀÌ°í CVD ¿¹¹æÇýÅáè
ÀÌ»óµ· ±âÀÚ 2021-01-04 18:15
¶óÀÎ
[Sub Story] °íÁß¼ºÁö¹æÇ÷Áõ ¿Ö¡¤¾î¶»°Ô Ä¡·áÇØ¾ß Çϳª? ÀÌ»óµ· ±âÀÚ 2021-01-04 18:13
[Conference Report] ¡®È¯ÀÚ Á߽ɡ¯ °íÇ÷¾Ð + ÀÌ»óÁöÁúÇ÷Áõ °ü¸® °í·ÁÇØ¾ß ÀÓ¼¼Çü ±âÀÚ 2020-11-02 14:26
[Interview] ¡°ASCVD¿¡¼­ ¡®¾ÈÀüÇÑ¡¯ Áß¼ºÁö¹æ °­ÇÏ ½ºÅ¸Æ¾ Àü·«¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-13 09:43
[Sub Story]

ÄÝ·¹½ºÅ×·ÑÈí¼ö¾ïÁ¦ ¿¡Á¦Æ¼¹Ìºê

½ºÅ¸Æ¾ º´¿ë ÆÄÆ®³Ê·Î ÀÚ¸®Àâ¾Æ

ÀÌ»óµ· ±âÀÚ 2020-10-13 09:41
[Sub Story] Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ¼­±¸È­ ÆÐÅÏ ¶Ñ·Ç ÀÌ»óµ· ±âÀÚ 2020-10-13 09:41
¶óÀÎ
[Cover Story] Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ¡®°øÆ÷ÀÇ 3ÁßÁÖ¡¯ º»°ÝÈ­
ÀüÅëÀû Ư¼º¿¡ ¼­±¸È­ °ãÄ¡´Â °úµµ±â
¡èLDL-C, ¡èTG, ¡éHDL-C ¸ðµÎ ½É°¢
ÀÌ»óµ· ±âÀÚ 2020-10-13 09:38
[Sub Story] Áß¼ºÁö¹æ ¿©ÀüÈ÷ °­¼¼ ÀÌ»óµ· ±âÀÚ 2020-10-13 09:17
[Late Breaking Studies] ÇÇŸ¹Ù½ºÅ¸Æ¾, °í°­µµ ½ºÅ¸Æ¾°ú À¯»çÇÑ ½É³úÇ÷°üÇýÅà º¸°í ÀÓ¼¼Çü ±âÀÚ 2020-10-12 18:29
[Interview] ¡°ÇÇŸ¹Ù½ºÅ¸Æ¾À¸·Î ´ç´¢º´ À§Çè¾øÀÌLDL-C ¸ñǥġ ´Þ¼º °¡´É¡± ÀÌ»óµ· ±âÀÚ 2020-10-12 18:24
[Sub Story] LDL-C ¸ñǥġ ÇÏÇâÁ¶Àý 1µî°ø½ÅÀº ½ºÅ¸Æ¾ ÀÌ»óµ· ±âÀÚ 2020-10-12 18:11
¶óÀÎ
[Sub Story] LDL-C ¸ñǥġ ±Þ°­ÇÏ¿¡´Â º´¿ë¿ä¹ý ÀÖ¾ú´Ù ÀÌ»óµ· ±âÀÚ 2020-10-12 17:35
[Expert Opinion] Çѱ¹ÀÎ ÀÌ»óÁöÁúÇ÷Áõ ¸ÂÃãÄ¡·á ±Ù°Å·Î ±â´ë THE MOST 2020-10-12 17:32
[Interview] ¡°ASCVD ¿¹¹æ¡¤°ü¸®, Áß¼ºÁö¹æµµ ÇÙ½ÉÀÎÀÚ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2020-10-12 16:10
[Sub Story] ³úÁ¹Áß °ü¸®, Ä¡¸Å¿¹¹æ¿¡ ´ëÇÑ ¡®½ÇÇö °¡´ÉÇÑ¡¯ Àü·« ÀÓ¼¼Çü ±âÀÚ 2020-08-13 16:12
[Sub Story] ¡°Çѱ¹ÀÎ AMI Ä¡·áÀü·«, ¡®È®½Å¡¯°¡Áö°í Àû¿ëÇÒ ¼ö ÀÖ´Â ±â¹Ý ´ÙÁ³´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2020-08-13 16:10
Back to Top